Ashland Inc.

Day range

$72.47 – $73.55

Open

$73.04

Prev close

$72.99

Volume

89.36K

Market cap

$3.34B

Shares out

45.81M

P/E

60.77

P/S

1.81

P/B

1.79

P/FCF

14.10

ROE

2.9%

ROA

1.2%

Debt/Equity

0.73

Div yield

2.27%

As of Oct 23, 2026

• Credit facilitySep 25, 2026

  On September 24, 2026, Ashland Inc., certain wholly owned subsidiaries, Bank of America, N.A. as administrative agent and structuring agent, Bank of America Europe DAC as committed purchaser, and the other parties thereto entered into a Deed of Amendment and Restatement relating to the Company's existing European accounts receivable securitization program. The parties amended and restated the Receivables Purchase Agreement and Master Framework Agreement.

• Credit facilityJul 31, 2026

  On July 30, 2026, Ashland Inc. entered into the Fifth Amendment to the Receivables Purchase Agreement...the accounts receivable securitization facility under the RPA will provide for commitments of up to $70 million through the RPA's termination date, which has been extended to July 28, 2028.

• Preliminary resultsJul 28, 2026

  On July 28, 2026, Ashland Inc. ("Ashland") announced preliminary third quarter results, which are discussed in more detail in the news release (the "News Release") attached to this Current Report on Form 8-K ("Form 8-K") as Exhibit 99.1

• Activist investor campaignJul 28, 2026

  On July 27, 2026, the Company entered into a Cooperation Agreement (the "Cooperation Agreement") with Ancora Holdings Group, LLC ("Ancora") and the other persons and entities listed on Schedule A thereto (together with Ancora, the "Investor Group") regarding the appointment of Mr. Thomas and Mr. Spizzo and the formation of the Capital Allocation Advisory Committee. Pursuant to the Cooperation Agreement, the Investor Group agreed to abide by certain voting commitments, customary standstill obligations and mutual non-disparagement provisions.

• Credit facilityMay 29, 2026

  Ashland Inc. entered into a Second Amended and Restated Credit Agreement providing for a $500 million five-year revolving credit facility (including a $125 million letter of credit sublimit). The Credit Agreement amends and restates the Amended and Restated Credit Agreement dated as of July 22, 2022.

• CBTCabot Corporation-0.63%
• ALBAlbemarle Corporation+0.44%

Days to cover

6.7

Short interest

4.62M

Avg volume

690.82K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• ASH's Shares Rally 30% in 6 Months: What's Driving the Upside?
  positiveZacks Investment Research· Sep 29, 2026
• Here's Why You Should Retain ASH Stock in Your Portfolio Now
  neutralZacks Investment Research· Sep 16, 2026
• Ashland to host Innovation Day for analysts and investors
  positiveGlobeNewswire Inc.· Aug 31, 2026
• Global Pharmaceutical Surfactants Market Size/Share Worth USD 6.93 Billion by 2035 at a 4.42% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
  positiveGlobeNewswire Inc.· Jul 28, 2026
• Ashland responds to investor presentation by Ancora Alternatives LLC
  neutralGlobeNewswire Inc.· Jun 10, 2026